Lataa...
Autophagy inhibition sensitizes LY3023414-induced anti-glioma cell activity in vitro and in vivo
PI3K-AKT-mTOR signaling is a valuable treatment target for human glioma. LY3023414 is a novel, highly-potent and pan PI3K-AKT-mTOR inhibitor. Here, we show that LY3023414 efficiently inhibited survival and proliferation of primary and established human glioma cells. Meanwhile, apoptosis activation w...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5716781/ https://ncbi.nlm.nih.gov/pubmed/29228741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22147 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|